Final sale of medicinal products in relation to safety features after the change in registration

The SIDC (Czech NCA = SÚKL) emphasizes the obligation of operators authorized to dispense medicinal products, as specified in § 82, paragraph 3(i) of the Medicinal Products Act, to verify safety features and decommission unique identifiers in accordance with regulations, even when selling remnants of medicinal products whose registration has changed.

It is permissible to sell both serialized medicinal products, which can be distributed/sold during their useful life, and medicinal products without safety features that have been newly added to the so-called "white list" following a change in registration. 

For more information on the sale of medicinal product remnants after the approval of a change in registration, please visit the State Institute for Drug Control website.